Callan JMB (NASDAQ:CJMB) Issues Quarterly Earnings Results

Callan JMB (NASDAQ:CJMB) issued its quarterly earnings results on Friday. The company reported ($0.59) earnings per share (EPS) for the quarter, Zacks reports. Callan JMB had a negative return on equity of 166.44% and a negative net margin of 139.14%.

Callan JMB Trading Up 1.0%

Callan JMB stock traded up $0.01 during trading hours on Friday, hitting $1.01. 16,104 shares of the stock traded hands, compared to its average volume of 105,185. The firm’s 50-day moving average price is $1.37 and its two-hundred day moving average price is $1.93. The company has a market cap of $5.69 million, a PE ratio of -0.56 and a beta of 0.35. Callan JMB has a one year low of $0.86 and a one year high of $5.88.

Insiders Place Their Bets

In other news, insider David J. Croyle acquired 14,805 shares of the business’s stock in a transaction on Friday, March 6th. The shares were acquired at an average cost of $1.76 per share, with a total value of $26,056.80. Following the transaction, the insider owned 789,805 shares in the company, valued at $1,390,056.80. The trade was a 1.91% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 73.87% of the company’s stock.

Institutional Trading of Callan JMB

A hedge fund recently raised its stake in Callan JMB stock. Creative Planning boosted its holdings in Callan JMB Inc. (NASDAQ:CJMB) by 41.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,008 shares of the company’s stock after acquiring an additional 50,000 shares during the quarter. Creative Planning owned 3.79% of Callan JMB worth $830,000 at the end of the most recent quarter.

Analyst Upgrades and Downgrades

CJMB has been the topic of several analyst reports. Wall Street Zen upgraded Callan JMB to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Callan JMB in a report on Wednesday, April 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.